What are natural treatment options for bacterial vaginosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Natural Treatment Options for Bacterial Vaginosis

Probiotics containing Lactobacillus rhamnosus at 10×10⁹ CFU/day for 10 days represent the most effective natural treatment for bacterial vaginosis, significantly improving cure rates and reducing recurrence when used as adjunctive therapy with standard antibiotics. 1

Evidence-Based Probiotic Therapy

Most Effective Probiotic Regimen

  • Lactobacillus rhamnosus TOM 22.8 at 10×10⁹ CFU/day for 10 days is the single most effective probiotic strain and dose, significantly improving Nugent scores, vaginal pH, vaginal microbiota composition, and reducing bacterial vaginosis recurrence rates 1
  • This represents the highest quality recent evidence (2025 systematic review) specifically evaluating probiotic species, strains, and optimal dosing 1

Alternative Probiotic Strains

  • Lactobacillus crispatus, L. plantarum, and L. acidophilus show therapeutic potential at doses of 1×10⁸ to 5.4×10⁹ CFU/day for treatment durations ranging from 6 days to 4 months 1
  • Lactobacillus crispatus (CST I) is particularly associated with healthy vaginal status and may help prevent cervical disease progression 2

Probiotic Efficacy Data

  • Meta-analysis demonstrates that probiotic supplementation significantly improves cure rates in adult bacterial vaginosis patients (risk ratio 1.53; 95% CI 1.19–1.97) 3
  • When restricted to high-quality studies, the benefit is even more pronounced (risk ratio 1.60; 95% CI 1.16–2.22) 3
  • The combination of oral metronidazole with probiotics shows superior microbiological cure compared to conventional antibiotics alone (OR 0.09; 95% CI 0.03 to 0.26) 3

Safety Profile

  • Reported side effects from probiotic therapy are mild and self-limiting 1
  • No nosocomial probiotic infections have been reported in clinical studies 3

Herbal Medicine Options

Cymbopogon olivieri (Lemongrass)

  • Cymbopogon olivieri-based vaginal products demonstrate efficacy similar to metronidazole for treating bacterial vaginosis, significantly reducing burning, itching, malodor, abnormal discharge, pH, clue cells, and positive whiff test (p<0.05) 4
  • This represents a suitable alternative when patients prefer herbal therapy over conventional antibiotics 4

Combination Herbal Therapies

  • Combinations of Prangos ferulacea, Berberis vulgaris, Myrtus communis, and Quercus brantii with metronidazole produce superior results compared to metronidazole alone 5
  • Forzejehe (combination of Tribulus terrestris + Myrtus communis + Foeniculum vulgare + Tamarindus indica) demonstrates therapeutic effects similar to metronidazole when used alone 5
  • Zataria multiflora and Calendula officinalis show efficacy comparable to metronidazole monotherapy 5

Thymbra capitata Essential Oil

  • Vaginal sheets containing Thymbra capitata essential oil at 0.32 µL/mL significantly reduce bacterial load of all tested Gardnerella species in vitro 6
  • This formulation promotes immediate relief of vaginal discharge and unpleasant odor while acting directly on bacterial vaginosis pathogens 6

Critical Clinical Guidance

When Natural Treatments Are Appropriate

  • Natural treatments should be used as adjunctive therapy alongside standard antibiotic treatment, not as monotherapy, to maximize cure rates and minimize recurrence 3, 1
  • The probiotic/metronidazole combination regimen is more effective than either treatment alone 3

When Natural Treatments Are NOT Appropriate

  • Do NOT use natural treatments as monotherapy in pregnant women—standard CDC-recommended antibiotic regimens are required (clindamycin cream in first trimester, oral metronidazole after first trimester) 7, 8
  • Do NOT delay standard antibiotic treatment before surgical abortion or hysterectomy—metronidazole substantially reduces post-procedure pelvic inflammatory disease 7, 9
  • Do NOT use natural treatments alone in high-risk pregnant women with history of preterm delivery, as systemic antibiotic therapy is needed to address subclinical upper genital tract infection 7, 8

Important Limitations

  • Current evidence for herbal medicines comes from smaller studies with heterogeneous methodologies; larger standardized trials are needed 1, 5
  • Some herbal products (propolis, Brazilian pepper tree) show less therapeutic effect than metronidazole and should not be considered equivalent alternatives 5
  • Thymbra capitata vaginal sheets show some toxicity at certain concentrations and are intended only for short-term treatment 6

Practical Treatment Algorithm

For non-pregnant women seeking natural options:

  1. First-line: Oral metronidazole 500 mg twice daily for 7 days PLUS Lactobacillus rhamnosus TOM 22.8 at 10×10⁹ CFU/day for 10 days 7, 1
  2. Alternative (if patient refuses antibiotics): Cymbopogon olivieri vaginal product for 7 days, with close follow-up 4
  3. For recurrence prevention: Continue Lactobacillus probiotics (L. crispatus, L. rhamnosus, or L. plantarum) at 1×10⁸ to 10×10⁹ CFU/day for 1-4 months after completing antibiotic therapy 1

For pregnant women:

  • Natural treatments are NOT recommended as monotherapy—use CDC-recommended antibiotic regimens (clindamycin cream first trimester, oral metronidazole second/third trimester) 7, 8
  • Probiotics may be added as adjunctive therapy after antibiotic treatment, but evidence in pregnancy is limited 1

Partner Treatment Consideration

  • Groundbreaking 2025 evidence demonstrates that treating male partners with combined oral metronidazole 400 mg twice daily PLUS topical 2% clindamycin cream for 7 days reduces bacterial vaginosis recurrence from 63% to 35% (absolute risk reduction 2.6 recurrences per person-year; P<0.001) 10
  • This represents a major paradigm shift from previous CDC guidance recommending against partner treatment 10, 11
  • The American College of Obstetricians and Gynecologists issued a 2025 Clinical Practice Update endorsing concurrent sexual partner therapy to prevent recurrence 11

References

Research

Microbiome, Human Papillomavirus and Cervical Carcinogenesis.

Current topics in microbiology and immunology, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Effect of Cymbopogon olivieri-based herbal vaginal product on bacterial vaginosis.

Revista da Associacao Medica Brasileira (1992), 2024

Guideline

Bacterial Vaginosis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Treatment of Bacterial Vaginosis During Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Treatment of Bacterial Vaginosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Male-Partner Treatment to Prevent Recurrence of Bacterial Vaginosis.

The New England journal of medicine, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.